Karen Seiter - Concepedia

Author

Karen Seiter

Also Known As

K P Seiter, K Seiter, K. SEITER, K. Seiter, K.P. Seiter, KAREN SEITER, Karen P Seiter, Karen P. Seiter, Karen Seiter, Karen Seiter .

212

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

New York Medical College Memorial Sloan Kettering Cancer Center Westchester Medical Center The University of Texas MD Anderson Cancer Center Cornell University

About

Karen Seiter is an author at New York Medical College specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	27	1.2K
2	Health Sciences	9	9	578
3	Cell Biology	4	4	112
4	Blood Transplantation	2	2	31
5	Public Health	1	1	17

Karen Seiter

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasoneversus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer Nancy Kemeny, Karen Seiter, Donna Niedzwiecki, Cancer Fudr Versus FudrGastroenterologyPathologyPharmacotherapyOncology	1992	245
Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study Jörge E. Cortes, Joseph O. Moore, Richard T. Maziarz, Journal of Clinical Oncology	2010	193
High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia Susan O’Brien, Gary J. Schiller, John Lister, Journal of Clinical Oncology	2012	185
The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase Karen Seiter, Eric J. Feldman, Tauseef Ahmed, Blood	1996	183
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial Stefan Faderl, Meir Wetzler, David A. Rizzieri, Journal of Clinical Oncology	2012	176
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicity Nancy E. Kemeny, Anas Younes, Karen Seiter, Cancer	1990	139
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial Justin M. Watts, Maria R. Baer, Jay Yang, The Lancet Haematology Phase 1/2Hematological MalignancyMyelodysplastic SyndromeMedicineMixed-phenotype Acute Leukemia	2022	111
Toxicity of the topoisomerase II inhibitors Karen Seiter Expert Opinion on Drug Safety	2005	105
Induction of ATM Activation, Histone H2AX Phosphorylation and Apoptosis by Etoposide: Relation to Cell Cycle Phase Toshiki Tanaka, H. Dorota Halicka, Frank Traganos, Cell Cycle	2007	101
Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update Nancy E. Kemeny, Karen Seiter, John A. Conti, Cancer	1994	101

Page 1